Bruker announced on September 4 that its energy and supercon technologies unit, Bruker Energy & Supercon Technologies (BEST), has entered a supply collaboration with Luvata Materials & Solutions to scale up production of RRP superconductors for magnetic confinement fusion. The deal comes as fusion projects ramp up globally and follows a month after Bruker's core instruments business showed signs of stabilizing. BEST revenue rose 11.9% year over year to $74.2 million in the second quarter, with organic growth of 8.9%, while first-half revenue climbed 12.3% to $141 million, helping expand non-GAAP operating margin to 14.1% from 9% and lifting non-GAAP diluted EPS to $0.49 from $0.32. However, GAAP results swung to a $65.3 million operating loss due to a $134.9 million non-cash goodwill charge, and total company organic revenue growth was only 2.8% in the quarter. The Luvata agreement has no disclosed contract value or timeline, and BEST's revenue is less than 9% of total company revenue, leaving investors to weigh the fusion potential against a still-soft academic market.
Bruker's BEST unit entered a supply collaboration with Luvata to scale up RRP superconductor production for fusion projects, a concrete product/supply deal.
Luvata is the named partner scaling up RRP superconductor production, but no contract value or timeline was disclosed.
Related news
Japan
▲
Helical Fusion Raises JPY 3.23 Billion in Series B Second Close as Fuji Electric Joins as Investor and Partner
Helical Fusion Co., Ltd. has completed a JPY 3.23 billion Series B second close, roughly USD 20.6 million, with Fuji Electric Co., Ltd. joining as both an investor and an Official Partner of the company's Helix Program. Other new investors in the second close include HAZAMA ANDO CORPORATION, Fujikura Ltd., TOKYO GAS CO., LTD., KKT LLC, and URATA Co., Ltd., along with the individual-investor fund Ecrowd NEXT and multiple corporate and individual investors. Together with other funding, including the Gifu Prime Startup Support Subsidy administered by the Gifu Prefecture Industrial Economic Promotion Center, Helical Fusion's cumulative funding has reached approximately JPY 13.15 billion, or approximately USD 83.8 million, including grants and loans. The new capital will accelerate the Helix Program, the company's roadmap toward integrated demonstration with its Helix HARUKA device and subsequent net-electricity generation with Helix KANATA, its first fusion power plant, in the 2030s. Fuji Electric, founded in 1923, began working with Helical Fusion in 2025 under an agreement to supply power supply equipment for high-temperature superconducting magnet development, and its participation expands the industrial capabilities being brought into the Helix Program. Construction of Helix HARUKA is progressing at the National Institute for Fusion Science campus in Toki City, Gifu Prefecture, with more than 30 Japanese companies contributing to its development and manufacturing.
Commonwealth Fusion Systems Places Largest-Ever HTS Tape Order With Fujikura
Commonwealth Fusion Systems has signed a landmark long-term supply agreement with Fujikura Ltd. to purchase more than 10,000 km (3 GA-m) of high-temperature superconducting tape, the largest single order of its kind for HTS tape. The tape will be used in the development of CFS' ARC power plants, starting with the first grid-scale plant at the Fall Line Fusion Power Station in Chesterfield County, Virginia. As part of the agreement, Fujikura is investing in expanding its manufacturing capacity to deliver the tape at scale. CFS CEO and co-founder Bob Mumgaard said the partnership shows the company is actively placing orders and preparing to execute its ARC power plant once its SPARC fusion machine achieves Q>1. Fujikura President and CEO Naoki Okada said the deal strengthens Fujikura's position as a key HTS tape supplier for ARC power plants while building a long-term business platform for the 2030s and beyond.
Fusion Energy › Magnets & HTS Superconductors ▲Supply
Fusion Energy › Fusion Pure-plays (Developers) ▲Supply
5803.JP · Demand · Positive Fujikura signed a landmark long-term supply agreement to deliver over 10,000 km of HTS tape to CFS, the largest single order of its kind.
Commonwealth Fusion Systems · Supply · Positive CFS secured a large-scale HTS tape supply deal with Fujikura to build its ARC power plants, with Fujikura expanding capacity to deliver at scale.
UBS Flags AI Science Shift as Investment Theme After OpenAI Proof
UBS Wealth Management says artificial intelligence is moving beyond text generation into scientific research, opening investment opportunities across AI infrastructure, pharmaceuticals, nuclear fusion, industrial materials and utilities. The shift was highlighted by OpenAI's recent mathematical proof related to the Navier-Stokes equations, a centuries-old fluid dynamics problem and one of seven Millennium Prize Problems, which OpenAI tackled using 10,000 autonomous AI agents working in parallel for 88 hours before formalizing the proof with Lean, a system for machine-checked mathematical validation. In pharmaceuticals, multi-agent AI systems can simulate millions of protein variations in the cloud, and more than 170 AI-designed programs are already in development or clinical evaluation, including Phase III trials. In nuclear fusion, reinforcement-learning systems can predict plasma disruptions around 200 milliseconds before they occur and adjust magnetic coils thousands of times per second, while AI models in materials science can test millions of elemental combinations daily in search of properties for lighter, higher-density batteries, lower-heat computing hardware and potential room-temperature superconductors. The broader investment case centers on AI becoming a tool for automating scientific research rather than simply generating content, with companies exposed to AI infrastructure, pharmaceuticals, industrial materials and utilities positioned to benefit as these technologies move toward commercial applications.
Global private investment in nuclear fusion hit a record $4.48 billion in 2025, up 69% from a year earlier, as major energy companies like Eni, Equinor, Chevron, Shell, and Cenovus ramp up their commitments. Eni plans to deploy a commercial fusion power plant in Europe by the early 2040s, building on its investment in Commonwealth Fusion Systems and a $1 billion agreement to buy electricity from the startup's first U.S. plant. Eni is also forming a joint venture with the UK Atomic Energy Authority to develop fuel systems for fusion reactors, targeting a large-scale tritium fuel-cycle facility by 2028. Commonwealth Fusion Systems raised another $1 billion in July, bringing its total funding to $4 billion, and its planned 400-MW ARC facility in Virginia is the first fusion project to apply for grid interconnection. Chevron has backed TAE Technologies and Zap Energy, while Shell invested in Zap's $130 million Series D round, and Cenovus's early bet on General Fusion is moving toward a Nasdaq listing.
Global Private Nuclear Fusion Investments Surge 69% to Record $4.48 Billion in 2025
Global private investments in nuclear fusion hit a record $4.48 billion in 2025, a 69% surge driven by AI data center energy demands and rising energy security concerns. The Fusion Industry Association reports that about 71% of fusion companies now expect to deliver commercial power to the grid by the 2030s, with firms inking site selections and power purchase agreements with major tech companies. Helion Energy signed a binding power purchase agreement with Microsoft for at least 50 megawatts by 2028, backed by a $465 million Series G round that valued the company at $15.5 billion, and broke ground on its Orion facility in Washington. Commonwealth Fusion Systems raised $863 million in an oversubscribed Series B2 round, bringing its total funding to nearly $3 billion, to develop its SPARC demonstration device and design the ARC commercial plant in Virginia. Proxima Fusion raised €411 million, becoming Europe's best-funded fusion company at a €2.4 billion valuation, with Google and RWE each contributing €25 million to accelerate its stellarator-based Alpha demonstrator near Munich.